SCHEMBL2439752

SCHEMBL2439752

COCC(O)n1cc(C(=O)Nc2ccc(S(C)(=O)=O)cc2)c(C)c1-c1ccccc1C(F)(F)F

nearest known ligand 0.66

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
NR3C2 P08235 6/20 0.66
ELANE P08246 4/20 0.39
PTPRC P08575 1/20 0.39
LMNA P02545 2/20 0.38
MAPT P10636 1/20 0.38
TDP1 Q9NUW8 1/20 0.38
CDK1 P06493 1/20 0.36
CDK2 P24941 1/20 0.36
KDR P35968 1/20 0.36
RORC P51449 1/20 0.36
AVPR2 P30518 2/20 0.35
GPR27 Q9NS67 2/20 0.35
PTGES O14684 1/20 0.35
ALDH1A1 P00352 1/20 0.35
POLB P06746 1/20 0.35
GAA P10253 1/20 0.35
MAOA P21397 1/20 0.35
MAOB P27338 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1382292 0.87 NR3C2 (0.72) NR3C2ELANEPTPRCLMNAMAPT
SCHEMBL2540736 0.86 NR3C2 (0.79) NR3C2ELANEPTPRCLMNAMAPT
SCHEMBL2357954 0.86 NR3C2 (0.79) NR3C2ELANEPTPRCLMNAMAPT
SCHEMBL2439584 0.83 NR3C2 (0.79) NR3C2PTPRCLMNAMAPTTDP1
SCHEMBL28178744 0.81 NR3C2 (0.73) NR3C2PTPRCLMNAMAPTTDP1
SCHEMBL4638193 0.81 NR3C2 (0.39) NR3C2ALDH1A1
SCHEMBL17646149 0.81 NR3C2 (0.81) NR3C2PTPRCLMNAMAPTTDP1
SCHEMBL29571805 0.80 NR3C2 (1.00) NR3C2PTPRCLMNAMAPTTDP1
SCHEMBL1381714 0.80 NR3C2 (1.00) NR3C2PTPRCLMNAMAPTTDP1
SCHEMBL2441069 0.79 NR3C2 (0.71) NR3C2PTPRCLMNAAVPR2GPR27

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8026237-B2 For modulating activity of one or more steroid nuclear receptors and for treatment, prevention, or amelioration of symptoms of disease or disorder related to the activity of receptors; 5-benzo[b]thiophen-2-yl-1,4-dimethyl-1H-pyrrole-3-carboxylic acid (4-methanesulfonyl-phenyl)-amide EXELIXIS, INC. (US) 2011-09-27 US claimed
US-8026237-B2 For modulating activity of one or more steroid nuclear receptors and for treatment, prevention, or amelioration of symptoms of disease or disorder related to the activity of receptors; 5-benzo[b]thiophen-2-yl-1,4-dimethyl-1H-pyrrole-3-carboxylic acid (4-methanesulfonyl-phenyl)-amide EXELIXIS, INC. (US) 2011-09-27 US disclosed